Thrombolysis for Acute Central Retinal Artery Occlusion: Is it Time?

American Journal of Ophthalmology

Volumn 146, Issue 5, 2008, Pages 631-634

  Biousse, Valérie ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

BLOOD CLOT LYSIS; CENTRAL RETINA ARTERY OCCLUSION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; PRIORITY JOURNAL; TREATMENT INDICATION;

FIBRINOLYTIC AGENTS; HUMANS; OPHTHALMOLOGY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETINAL ARTERY OCCLUSION; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 54549127331     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.07.025     Document Type: Editorial

References (16)

1. Biousse V., Calvetti O., Bruce B.B., and Newman N.J. Thrombolysis for central retinal artery occlusion. J Neuroophthalmol 27 (2007) 215-230
2. Hayreh S.S., and Zimmerman M.B. Central retinal artery occlusion: visual outcome. Am J Ophthalmol 140 (2005) 376-391
3. Brown G.C. Retinal arterial obstructive disease. In: Ryan S.J. (Ed). Retina (1994), Mosby, St Louis, Missouri 1361-1377
4. Ivanisevic M., and Karelovic D. The incidence of central retinal artery occlusion in the District of Split, Croatia. Ophthalmologica 215 (2001) 245-246
5. Adams Jr. H.P., del Zoppo G., Alberts M.J., et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115 (2007) e478-e534
6. Higashida R.T., Furlan A.J., Roberts H., et al., Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 34 (2003) e109-e137
7. Mattle H.P. Intravenous or intra-arterial thrombolysis?. It's time to find the right approach for the right patient. Stroke 38 (2007) 2038-2040
8. Shaltoni H.M., Albright K.C., Gonzales N.R., et al. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?. Stroke 38 (2007) 80-84
9. Noble J., Weizblit N., Baerlocher M.O., and Eng K.T. Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review. Br J Ophthalmol 92 (2008) 588-593
10. Hattenbach L.O., Kuhli-Hattenbach C., Scharrer I., and Baatz H. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion. Am J Ophthalmol 146 (2008) 700-706
11. Aldrich E.M., Lee A.W., Chen C.S., et al. Local intraarterial fibrinolysis administered in aliquots for the treatment of central retinal artery occlusion: the Johns Hopkins Hospital experience. Stroke 39 (2008) 1746-1750
12. Hayreh S.S. Intra-arterial thrombolysis for central retinal artery occlusion. Br J Ophthalmol 92 (2008) 585-587
13. Suri M.F., Nasar A., Hussein H.M., et al. Intra-arterial thrombolysis for central retinal artery occlusion in United States: Nationwide In-patient Survey 2001-2003. J Neuroimaging 17 (2007) 339-343
14. Feltgen N., Neubauer A., Jurklies B., et al., EAGLE Study Group. Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study Report No. 1. Graefes Arch Clin Exp Ophthalmol 244 (2006) 950-956
15. Hayreh S.S., Zimmerman M.B., Kimura A., et al. Central retinal artery occlusion. Retinal survival time. Exp Eye Res 78 (2004) 723-736
16. Margo C.E., and Mack W.P. Therapeutic decisions involving disparate clinical outcomes: patient preference survey for treatment of central retinal artery occlusion. Ophthalmology 103 (1996) 691-696